Skip to main content
Journal of Ayurveda and Integrative Medicine logoLink to Journal of Ayurveda and Integrative Medicine
. 2022 Jul 16;14(1):100560. doi: 10.1016/j.jaim.2022.100560

“An integrative approach with Ayurveda and Traditional Chinese Acupuncture in post covid parosmia – A case study”

Akshatha K Bhat a,, Venugopalan Krishna Kumar b, Jim Daniel Johnson c
PMCID: PMC9287594  PMID: 35851219

Abstract

This case is about a post viral olfactory dysfunction due to SARS-CoV-2 infection, since six months treated effectively by a unique integrative approach with Ayurveda and Traditional Chinese Acupuncture (TCA). It started as a sudden onset of anosmia in the month of August 2020 with fever history two weeks prior. After three months Parosmia commenced which gradually worsened. A month later she experienced dysgeusia and nausea leading to tremendous stress and sleep disturbances. Ayurveda treatment included Shadbindu taila marsha nasya for seven days followed by Shadbindu taila pratimarsha nasya (intra nasal oil instillation) for a period of four months. Naradiya laxmivilasa rasa orally for one month. GV.20, LI.20, Ex.1, H.7, LI.11, GB.8, GB.21 and GV.25 Points were selected for TCA. The Indian Smell identification test score on day one of treatment was zero, day seven was four, at the end of one month was eight and after four months it was ten. Parosmia was assessed by VAS which was ten on day one and zero on day seven. We could achieve complete normalcy in olfactory function within four months of this treatment. This integrative approach was found to be safe and effective in treating Post covid parosmia.

Keywords: Ayurveda, Traditional Chinese acupuncture, Integrative approach, Parosmia

1. Introduction

This case reports a post viral olfactory dysfunction (PVOD) due to SARS-CoV-2 infection, since six months treated effectively by a unique integrative approach with Ayurveda and TCA. Post covid parosmia is not a minor issue since it causes serious problems with eating and mental well-being [1]. In an international study of people with recent smell loss, seven percentage of more than 4000 respondents reported experiencing parosmia [2]. But in a recent survey study of six month follow up, of a cohort of 434 subjects; almost half had parosmia [3]. A systematic review showed that there is no strong evidence for different pharmacologic agents in treating post viral olfactory dysfunction [4]. Ayurveda considers olfactory function being executed by Vatadosha [5] and Parthivadravya [6] (Kaphadosha) and hence olfactory dysfunction is due to vitiated vata and kapha dosha. In this case we included Marsha nasya and Pratimarshanasya (intra nasal oil instillation) with Shadbindu taila [7] and oral intake of Naradiya laxmivilasa rasa [8]. Clinical studies showed that TCA was effective in PVOD [9,10]. We report this case as the integrative approach resulted in rapid improvement of parosmia and quality of life.

2. Case presentation

We present a case of 20 years old female complaining of change in the perception of smell since six months. It commenced as a sudden onset of anosmia in the month of August 2020 with a fever history which had appeared two weeks prior. She underwent treatment for five days with oral antibiotics and nasal drops of which the details are not known. But there was no change in her anosmia. After three months she started perceiving foul smell while eating which gradually worsened. She had to avoid all her favorite foods and drinks due to the mal odor. A month later she started experiencing impaired sense of taste along with nausea while eating. This resulted in tremendous stress leading to sleep disturbances and she opted for Ayurveda Treatment. She was advised to undergo test for Covid IgG Antibodies and was found to be reactive that confirms the diagnosis of post Covid parosmia.

3. Clinical findings

Anterior Rhinoscopy was normal except for Type I DNS towards left. There was no history of any head injury, epilepsy, upper respiratory tract infections, chronic sinusitis and any medications. The patient had no other complaints pertaining to the nervous system except olfactory dysfunction or other symptoms in the post-covid period.

4. Diagnostic assessments

Olfactory function was assessed based on Indian Smell identification test (ISIT). ISIT score for anosmia scoring was zero [11]. Parosmia was evaluated based on quantitative and qualitative measures where in it showed severe alteration in quantitative aspect and VAS Score of ten in qualitative aspect [12]. The quantitative aspect was assessed with a scale of normal, mild alteration, moderate alteration and severe alteration.

4.1. Laboratory investigations

Hb-9.7 gm/dl, TC- 4.4 × 10˄3/μL, Nuetrophils-47%, lymphocytes-41%, eosinophils-6%, monocytes- 6%, Basophils- 0%, Platelet count- 311 × 10˄3/μL, RBC- 4.44 million/cumm, ANTI-SARS-COV-2(IgG)- 2.23 Reactive.

5. Therapeutic intervention

Ayurveda treatment given is depicted in Table 1. We selected GV.20, LI.20, Ex.1, H.7, LI.11, GB.8, GB.21 and GV.25 points for TCA. The therapeutic intervention of these points is depicted in Table 2. The schematic representation of the same given in Fig. 1

Table 3.

Ingredients of Shadbindu taila [7].

S·NO INGREDIENTS LATIN NAME QUANTITY
Tila Taila Sesamum indicum DC. 768 ml
Aja Dugdha Goats milk 3.072lts
Bhringaraja Eclipta alba Linn 3.072lts
Eranda Ricinus Comunis Linn 19 gms
Tagara Valeriana wallichii DC. 19 gms
Shatahva Anethum sowa Kurz. 19 gms
Rasna Pluchea lanceolata C·B.Clarke 19 gms
Jeevanthi Leptadinia retriculata (Retz.) Wt.etArn 19 gms
Saindhava Rock salt 19 gms
Bringa Cinnamomom zeylanicum Blume. 19 gms
Vidanga Embelia ribes Durm.f. 19 gms
Yashti Gylcerrhiza glabra Linn. 19 gms
Vishwaoushadha Zingiber officinalis Rosc.Ex.Smith 19 gms

Manufacturer: Ayukalp, Gujrat, India.

Table 4.

Ingredients of Naradiya Lakshmi vilasa rasa [8].

S·NO INGREDIENTS LATIN NAME QUANTITY
Abhraka Bhasma Purified and processed mica 10 gms
Shuddha Parada Herbal purified mercury 10 gms
Shuddha Gandhaka Herbal purified Sulphur 10 gms
Karpoora Cinnamon camphora Nees &Eberm. 10 gms
Jatiphala Myristica fragrans Henlt. 10 gms
Jatikosha Myristica fragrans Henlt. 10 gms
Vriddhadaru Argyrea speciosa Sweet. 10 gms
Dhattura Datura metel Linn 10 gms
Bhanga Cannabis sativa Linn 10 gms
Vidari Pueraria tuberosa DC. 10 gms
Shatavari Asperagus racemosus Willd. 10 gms
Nagabala Grewia populifolia Vahl. 10 gms
Atibala Abutilon indicum Linn. 10 gms
Gokshura Tribulus terrestris Linn 10 gms
Nichula Stryxnus nuxvomica Linn 10 gms
Nagavalli Piper betel Linn. 10 gms

Manufacturer: Dhootpapeshwar, Maharashtra, India.

Treatment outcome and follow up

Table 5.

Treatment outcome is portrayed in Table 5.

S.no Test Symptom Before treatment On day 7 of treatment After one month After 4 months
1 ISIT Anosmia 0 4 8 10
2 VAS Parosmia 10 0 0 0
3 Severity analysis Parosmia Severe alterations Normal Normal Normal

Showing the treatment outcomes in individual Symptom.

Table 1.

Treatment administered in this case.

Treatment Dose Anupana Time Duration
Nasya with Shadbindu taila done by the therapist. (Ingredients of Shadbindu taila is depicted in Table 2) Eight Bindu (4 ml) instilled into each nostrils Morning hours Seven days
Acupuncture done by the physician Afternoon 20 min duration for seven days
Naradiya laxmivilasa rasa tablet (Ingredients are depicted in Table 3) One tablet (250 mg) Lukewarm water Thrice daily after food One month
Pratimarsha nasya with Shadbindu taila done by the patient during follow up period. Two Bindu (1 ml) instilled into each nostrils Thrice daily Day eight to the end of four months

Depicting the treatment administered in this case.

Table 2.

Therapeutic intervention of TCA points [13].

S.no TCA Point Selected Indication Anatomical location Needling angle
GV.20 Powerful sedative point
Nasal obstruction.
At the vertex of the head in a depression in the midline of the cranium on the line which joins the tip of one ear to the other. The point is 7 cun above the posterior hairline, and 5 cun above the anterior hairline Slanting posteriorly 0.3–0.5 cun
LI.20 For all nasal disorders In the nasolabial grove, at the level of the midpoint of ala nasi Perpendicular or oblique insertion 0.3–0.5 cun.
Ex. 1 Rhinorrhea, Insomnia At the forehead, in the midpoint between the two medial end of the eyebrows Subcutaneous 0.3–0.5 cun horizontally downwards.
LI.11 All chronic infectious disorders
Antibiotic point or best Immunity improving point.
When the elbow is flexed, the point is found in the depression at the lateral end of the transverse cubital crease Perpendicular or oblique downward insertion 0.8–1.5 cun.
H.7 Anxiety, Insomnia, Psychosomatic disorders On the radial side of the tendon of the flexor carpi ulnaris, on the transverse crease of the wrist. Posteriolateral to pisiform bone. Perpendicular insertion 0.3–0.5 cun
GB.8 Depressive Psychosis, vertigo, Ear diseases Directly above the apex of the ear, 1.5 cun above the hairline. Subcutaneous 0.5–0.8 cun
GB.21 Endocrine point Midway between the tip of acromion and C7 spinous process, at the highest point of the shoulder Perpendicular 0.5–0.8 cun
GV.25 Nasal obstruction, Rhinorrhea On the region of the face, on the tip of the nose. Straight 0.2–0.3 cun

Fig. 1.

Fig. 1

Showing Pictorial depiction of 8 TCA points.

7. Discussion

The integrative approach was effective in improving the anosmia (ISIT score from zero to ten) after four months of treatment and in relieving parosmia completely within a week. There are evidences that hypothesize the pharmaco-dynamic effects of Marsha nasya/Pratimarsha nasya via olfactory bulb and neuro-epithelia, making them primary treatment modalities in parosmia [14]. Shadbindu taila was selected in treating this case as it pacifies vitiated Vata and Kapha dosha which causes parosmia. A study of skin irritation potential on rabbit skin showed that Shadbindu taila did not produce any adverse events and safe to use in humans [15]. Naradiya laxmivilasa rasa reduces vitiated Vatakapha dosha and it is indicated in nasal disorders as well.

Traditional theory of acupuncture including Yin and Yang theory and Yuan source points stimulate the vital energy of the regular meridians, regulates the functional activities of the internal organs, reinforces the antipathogenic factors and eliminates the pathogenic factors. The aim of acupuncture is to restore physical balance and to bring yin and yang into equilibrium. The effectiveness of certain specific acupuncture points such as distal points and confluent points can be explained based on the Thalamic neuron theory [16]. The Thalamic Neuron Theory postulates that the central nervous system is involved in all disease processes, it maintains homeostasis for the entire body by sending commands to the periphery. Pathologically habituated states can be reversed by dehabituation through manipulation or rectification of the abnormal neural circuits by physical means (physical neuromodulation) like acupuncture [17]. In this case pathologically habituated state refers to altered smell perception which can be dehabituated and restore the normal smell perception with the help of acupuncture.

In general, principles used in selection of TCA points are a) all acupuncture points treat the disease of the pathway of channel and their pertaining organs. b) Acupuncture points have an effect on the surrounding area of its location therefore useful for treating diseases of surrounding area [18]. Based on these principles eight TCA points were selected for treating this patient. The TCA points GV.20, LI.20, Ex.1, LI.11, GV.25 were selected due to their indication in nasal disorders. H.7 was selected since its mainly indicated in anxiety and sleep disturbance [13]. Acupressure on GB.21 TCA point is believed to reduce anxiety level which in turn helps in creating calmness and balance throughout the body and mind [19]. GB.8 was selected based on the effect of acupuncture point on the surrounding area of its location [13]. Since Ayurveda and Traditional Chinese Medicine (TCM) have common philosophical back ground [20] and TCA is a non-pharmacological intervention, we could infer that there will be no side effects by this unique integrative approach. There was considerable improvement in her quality of life in terms of sleep, food intake and psychological stress.

8. Conclusion

Post covid parosmia can hamper the quality of life in many ways and should be treated effectively by all means for a faster recovery. In this case, integrative approach of Ayurveda and TCA cured parosmia within a week and anosmia in four months and was found safe as well. Taking leads from this case, it would be tested on larger samples in the near future and later incorporate into clinical guidelines for integrative management of post covid parosmia.

Source of funding

None.

Conflict of interest

The authors have no conflict of interest to declare.

Credit author statement

Akshatha K Bhat: Conceptualization, Methodology, Validation, Writing original draft. Krishna Kumar: Conceptualization, Resources, Writing – Review & editing. Jim Daniel Johnson: Conceptualization, Resources, Writing – Review & editing.

Footnotes

Peer review under responsibility of Transdisciplinary University, Bangalore.

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.jaim.2022.100560.

Appendix A. Supplementary data

The following is the supplementary data to this article:

Multimedia component 1
mmc1.docx (1.6MB, docx)

References

  • 1.Saniasiaya J. Narayanan P Parosmia post COVID-19: an unpleasant manifestation of long COVID syndrome Postgraduate. Medical Journal Published Online First. 31 March 2021 doi: 10.1136/postgradmedj-2021-139855. [DOI] [PubMed] [Google Scholar]
  • 2.Parma V., Ohla K., Veldhuizen M.G., Niv M.Y., Kelly C.E., Bakke Alyssa J., et al. More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020;45(7):609–622. doi: 10.1093/chemse/bjaa041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hopkins C., Surda P., Vaira L.A., Lechien J.R., Safarian M., Saussez S., et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021;59(1):26–31. doi: 10.4193/Rhin20.544. [DOI] [PubMed] [Google Scholar]
  • 4.Harless L., Liang J. Pharmacologic treatment for postviral olfactory dysfunction: a systematic review. Int Forum Allergy Rhinol. 2016;6(7):760–767. doi: 10.1002/alr.21727. [DOI] [PubMed] [Google Scholar]
  • 5.Shivaprasad Sharma Dr., editor. Sutra sthana. 3rd ed. Chaukhamba Sanskrit series office; Doshadivijnaneeya: 2006. p. 148. (Commentary Shashilekha of indu on astanga Samgraha of vagbhata). [Chapter 19] verse 2. Varanasi. [Google Scholar]
  • 6.Shivaprasad Sharma Dr., editor. Sutra sthana. 3rd ed. Chaukhamba Sanskrit series office; Dravyadivijnaneeya: 2006. p. 136. (Commentary Shashilekha of indu on astanga Samgraha of vagbhata). [Chapter 17] verse 6. Varanasi. [Google Scholar]
  • 7.Prof. Siddhinandan Mishra, edited with siddhiprada commentary, bhaishajya ratnavali, shirorogaadhikara. Chaukambha surabharati prakashan; Varanasi: 2017. p. 1020. [Chapter 65] verse 78-80. [Google Scholar]
  • 8.Prof. Siddhinandan Mishra, edited with siddhiprada commentary, bhaishajya ratnavali, shirorogaadhikara. Chaukambha surabharati prakashan; Varanasi: 2017. p. 193. [Chapter 5] verse 1200-1212. [Google Scholar]
  • 9.Vent J., Wang D.W., Damm M. Effects of traditional Chinese acupuncture in post-viral olfactory dysfunction. Otolaryngol Head Neck Surg. 2010;142(4):505–509. doi: 10.1016/j.otohns.2010.01.012. [DOI] [PubMed] [Google Scholar]
  • 10.Dai Q., Pang Z., Yu H. Recovery of olfactory function in postviral olfactory dysfunction patients after acupuncture treatment. Evid Based Complement Alternat Med. 2016 Feb 29 doi: 10.1155/2016/4986034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.George J., Jose T., Behari M. Use of Indian smell identification test for evaluating olfaction in idiopathic Parkinson's disease patients in India. Neurol India. 2013;61(4):365–370. doi: 10.4103/0028-3886.117598. [DOI] [PubMed] [Google Scholar]
  • 12.Bonfils P., Avan P., Faulcon P., Malinvaud D. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol Head Neck Surg. 2005;131(2):107–112. doi: 10.1001/archotol.131.2.107. [DOI] [PubMed] [Google Scholar]
  • 13.Cheng Xinnong, Chief, editors. Chinese acupuncture and moxibustion. 1st ed. Foreign languages press; China: 1987. [Google Scholar]
  • 14.Radhika C., Kumar G.V., Mihirjan K. A randomized controlled clinical trial to assess the efficacy of Nasya in reducing the signs and symptoms of cervical spondylosis. Ayu. 2012;33(1):73–77. doi: 10.4103/0974-8520.100316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Shailajan S., Menon S.N., Tiwari B.R., Singh A.S. Standardization of shadbindu taila: an ayurvedic oil based medicine. Ayu. 2013;34(1):103–107. doi: 10.4103/0974-8520.115442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Clinical acupuncture. Theories of acupuncture: Prof. Dr. Sir Anton jayasuriya. Medicina alternativeia International; Sri Lanka: 1987. p. 41. [Google Scholar]
  • 17.Lee T.N. Thalamic neuron theory: theoretical basis for the role played by the central nervous system (CNS) in the causes and cures of all diseases. Med Hypotheses. 1994;43(5):285–302. doi: 10.1016/0306-9877(94)90105-8. [DOI] [PubMed] [Google Scholar]
  • 18.Clinical acupuncture. Principles of acupuncture points selection: Prof. Dr. Sir Anton jayasuriya. Medicina alternativeia International; Sri Lanka: 1987. p. 405. [Google Scholar]
  • 19.Moradi Z., Akbarzadeh M., Moradi P., Toosi M., Hadianfard M.J. The effect of acupressure at GB-21 and SP-6 acupoints on anxiety level and maternal-fetal attachment in primiparous women: a randomized controlled clinical trial. Nurs Midwifery Stud. 2014;3(3) doi: 10.17795/nmsjournal19948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Patwardhan B., Warude D., Pushpangadan P., Bhatt N. Ayurveda and traditional Chinese medicine, 2005 medicine: a comparative overview. Evid Based Complement Alternat Med. 2005;2(4):465–473. doi: 10.1093/ecam/neh140. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (1.6MB, docx)

Articles from Journal of Ayurveda and Integrative Medicine are provided here courtesy of Elsevier

RESOURCES